UTMD Utah Medical Products


Data from SEC filings
Employee count
CEO pay ratio
CEO Salary
Median Employee Salary

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On May 7, 2021 at the Company’s annual meeting of stockholders, stockholders approved or indicated their preference on the following matters submitted to them for consideration:

Elected Kevin L. Cornwell as a director of the Company:

For 2,606,371Withheld 272,082Broker Non Votes 357,423

Elected Paul O. Richins as a director of the Company:

For 2,416,025Withheld 462,428Broker Non Votes 357,423

Ratified the selection of Haynie & Co. as the Company’s independent public accounting firm for the year ended December 31, 2021:

For 3,233,242Against 1,114Abstentions 1,520

Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion:

For 2,827,223Against 41,228Abstentions 10,002Broker Non Votes 357,423

The Company will include annual advisory stockholder votes on executive compensation in its proxy materials. Annual advisory stockholder votes will be held until at least the next required advisory vote on frequency of stockholder votes on the compensation of executives.